Assyro AI

FDA Orange Book · active-ingredient family

Thiamine hydrochloride

Thiamine hydrochloride is approved in 21 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

0

Brand (NDA)

21

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Generic (ANDA) products (21)

ProductApplicantApplicationTEApproved
THIAMINE HYDROCHLORIDEGLANDANDA 217800APFeb 24, 2025
THIAMINE HYDROCHLORIDEASPIROANDA 218471APNov 06, 2024
THIAMINE HYDROCHLORIDEONESOURCE SPECIALTYANDA 217181APOct 29, 2024
THIAMINE HYDROCHLORIDECAPLINANDA 215692APMar 06, 2023
THIAMINE HYDROCHLORIDEEUGIA PHARMAANDA 208703APApr 20, 2022
THIAMINE HYDROCHLORIDESAGENT PHARMS INCANDA 206106APDec 01, 2017
THIAMINE HYDROCHLORIDEMYLAN INSTITUTIONALANDA 091623APJun 25, 2012
THIAMINE HYDROCHLORIDEHOSPIRAANDA 040079May 03, 1996
THIAMINE HYDROCHLORIDEEPIC PHARMA LLCANDA 087968Oct 01, 1982
BETALIN SRLDLILLYANDA 080853Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEABRAXIS PHARMANDA 080509Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEBEL MARANDA 080718Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEBEL MARANDA 080712Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEDELL LABSANDA 083775Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDE×2DR REDDYSANDA 080571APApproved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDERLDFRESENIUS KABI USAANDA 080556APApproved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDELUITPOLDANDA 080667Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEPARKE DAVISANDA 080770Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDE×2WATSON LABSANDA 083534Approved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEWEST-WARD PHARMS INTANDA 080575APApproved Prior to Jan 1, 1982
THIAMINE HYDROCHLORIDEWYETH AYERSTANDA 080553Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Thiamine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.